Drawing for DRUG360

USPTO serial 87910421

DRUG360

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
OEHRLEIN, STEFAN M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DRUG360?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joel N. Bock

Joel N. Bock Dentons US LLPWacker Drive Station, Willis TowerP.O. Box #061080Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
009downloadable software that enables users to access a proprietary on-line database featuring pharmaceutical and medical drug data; downloadable software tools featuring pharmaceutical and drug data, namely, providing downloadable software used for accessing a proprietary on-line database featuring pharmaceutical and medical drug data and analyzing the pharmaceutical and medical drug data; a proprietary searchable computer database featuring scientific information, medical information, business information, and healthcare information related to pharmaceutical and medical drug data, downloadable from the InternetACTIVE—
035providing a proprietary searchable computer database, accessible via the Internet, featuring business information related to pharmaceutical and medical drug dataACTIVE—
042providing a proprietary database via the Internet featuring pharmaceutical and drug data, namely, providing an Internet website featuring technology that enables users to access, and provides users with temporary use of non-downloadable on-line computer software for accessing a proprietary database featuring pharmaceutical and medical drug data; providing software tools via the Internet featuring pharmaceutical and drug data, namely, providing a website featuring on-line non-downloadable software used for accessing a proprietary database featuring pharmaceutical and medical drug data and analyzing the pharmaceutical and medical drug data; providing a proprietary searchable computer database, accessible via the Internet, featuring scientific information related to pharmaceutical and medical drug dataACTIVE—
044providing a proprietary searchable computer database, accessible via the Internet, featuring medical information and healthcare information related to pharmaceutical and medical drug dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 7, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 7, 2019EXT1SOU EXTENSION 1 FILED—
Nov 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 7, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 7, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 3, 2019ALIEASSIGNED TO LIE—
Jan 29, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 30, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 30, 2018EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Nov 30, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Nov 8, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 12, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 4, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 4, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 4, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 28, 2018DOCKASSIGNED TO EXAMINER—
May 16, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance